BioSpace News Archive

Innovent Biologics and LG Chem Life Sciences announced that the two parties have entered into a strategic collaboration and license agreement regarding LG Chem’s Tigulixostat, a late-stage novel non-purine xanthine oxidase inhibitor for the chronic management of hyperuricemia in patients with gout disease.

BIOASIS TECHNOLOGIES INC. is pleased to announce that it will be holding an investor call on Tuesday, December 20th, 2022 at 11:00am EST to discuss the recently announced merger with Midatech Pharma plc.

Axcella Therapeutics, a biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator compositions, announces a repositioning of its strategy to focus on Long COVID and realize value from its platform and current programs.

Prothena Corporation plc announced that it priced an underwritten public offering of 3,250,000 of its ordinary shares at a price to the public of $56.50 per ordinary share, before the underwriting discount and estimated offering expenses.